Recent advancements in PARP inhibitors-based targeted cancer therapy is a research paper published in Precision Clinical Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA236878
NIDCR NIH HHS
Grant: R01 DE029173
National Institutes of Health
Grant: 5R01CA236878-03
Molecular and Epigenetic Control of Wnt/b-catenin-mediated oncogenesis by KDM4B
National Cancer Institute
FWCI
2.13
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals